Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women
- PMID: 12860342
- DOI: 10.1016/s0301-2115(03)00048-4
Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women
Abstract
The rapidly growing rates of human immunodeficiency virus (HIV) infection among women has prompted many challenging issues related to the management and consequences of HIV and its complications in this population. This paper reviews the current evidence with regard to various aspects of HIV infection in women. Special emphasis is placed on gender-differences as well as sex-specific manifestation of this disease, including epidemiology, viral load determination and disease progression, related morbidity, and anti-retroviral therapy. It is concluded that current advances in the understanding of HIV infection among women may lead to further refinement and optimization efforts in the management of HIV-infected women.
Similar articles
-
The epidemiology of the oral lesions of HIV infection in the developed world.Oral Dis. 2002;8 Suppl 2:34-9. doi: 10.1034/j.1601-0825.2002.00009.x. Oral Dis. 2002. PMID: 12164657 Review. No abstract available.
-
Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28. J Oral Pathol Med. 2009. PMID: 19453845
-
[Epidemiology of HIV/AIDS and other sexually transmitted diseases in women].Med Sci (Paris). 2008 Mar;24 Spec No 2:7-19. doi: 10.1051/medsci/2008242s7. Med Sci (Paris). 2008. PMID: 18681115 French. No abstract available.
-
Kaposi's sarcoma in HIV-infected women and men in Nigeria.AIDS Patient Care STDS. 2011 Nov;25(11):635-7. doi: 10.1089/apc.2011.0122. Epub 2011 Oct 3. AIDS Patient Care STDS. 2011. PMID: 21967494
-
[Current status of the female condom in Africa].Sante. 1997 Nov-Dec;7(6):405-15. Sante. 1997. PMID: 9503499 Review. French.
Cited by
-
beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL.Retrovirology. 2008 Sep 22;5:82. doi: 10.1186/1742-4690-5-82. Retrovirology. 2008. PMID: 18808673 Free PMC article.
-
Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.PLoS One. 2013 Apr 17;8(4):e62069. doi: 10.1371/journal.pone.0062069. Print 2013. PLoS One. 2013. PMID: 23614015 Free PMC article.
-
[Correlation between clinical apparatus-based differential diagnosis and neuropathological diagnosis in patients with AIDS].Nervenarzt. 2004 Aug;75(8):763-9. doi: 10.1007/s00115-004-1724-5. Nervenarzt. 2004. PMID: 15118826 German.
-
Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity.Curr Infect Dis Rep. 2005 Jan;7(1):73-78. doi: 10.1007/s11908-005-0026-9. Curr Infect Dis Rep. 2005. PMID: 15610674
-
ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.Synapse. 2010 Nov;64(11):829-38. doi: 10.1002/syn.20793. Synapse. 2010. PMID: 20340172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical